Chronic Administration of the Nitric Oxide Synthase Inhibitor, L-NAME, Increases Circulating Endothelin Levels in Guinea Pigs

References

• Arnal J.-F., Warin L., Michel J.-B. Determinants of aortic guanosine monophoshate in hypertension induced by chronic reductions of nitric oxide synthase. Journal of Clinical Investigation 1992; 90: 647–652
   PubMed Web of Science ®Google Scholar
• Boulanger C., Lüscher T. F. Release of endothelin from porcine aorta. Inhibition by endothelium-derived nitric oxide. Journal of Clinical Investigation 1990; 85: 587–590
   PubMed Web of Science ®Google Scholar
• Buxton I. L. O., Cheek D. J., Eckman D., Westfall D. F., Sanders K. M., Keef K. D. NG-nitro-L-arginine methylester and other alkyl esters of arginine are muscarinic receptor antagonists. Circulation Research 1993; 72: 387–395
   PubMed Web of Science ®Google Scholar
• Cacoub P., Dorent R., Maistre G., Nataf P., Carayon A., Piette J. C., Godeau P., Cabrol C., Grandjbakhch I. Endothelin-1 in primary pulmonary hypertension and the eisenmenger syndrome. American Journal of Cardiology 1993; 71: 448–449
   PubMed Web of Science ®Google Scholar
• Chin J. H., Azhar S., Hoffman B. B. Inactivation of endothelial derived relaxing factor by oxidized lipoproteins. Journal of Clinical Investigation 1992; 89: 10–18
   PubMed Web of Science ®Google Scholar
• Clark B. A., Halvorson L., Sachs B., Epstein F. H. Plasma endothelin levels in preeclampia: Elevation and correlation with uric acid levels and renal impairment. American Journal of Obstetrics and Gynecology 1992; 166: 962–968
   PubMed Web of Science ®Google Scholar
• Dzau V. J., Gibbons G. H. Endothelium and growth factors in vascular remodelling in hypertension. Hypertension 18 Suppl. III 1991; 15: III-121
   Google Scholar
• Fickling S. A., Williams D., Vallance P., Nussey S. S., Whitley G. St. J. Plasma concentration od endogenous inhibitors of nitric oxide synthesis in normal pregnancy and preeclampsia. Lancet 1993; 342: 242–243
   PubMed Web of Science ®Google Scholar
• Gardiner S. M., Compton A. M., Bennet T., Palmer R. M. J., Moncada S. Regional hemodynamic changes during ingestion of NG-nitro-L-arginine methyl ester in conscious Brattleboro rats. British Journal of Pharmacology 1990; 101: 10–12
   PubMed Web of Science ®Google Scholar
• Greer I. A., Leask R., Hodson B. A., Dawes J., Kilpatrick D. C., Liston W. A. Endothelin, elastase, and endothelial dysfunction in pre-eclampsia. Lancet 1991; 337: 558
   PubMed Web of Science ®Google Scholar
• Hirata Y., Emori T., Eguchi S., Kanno K., Imai T., Olata K., Marumo F. Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells. Journal of Clinical Investigation 1993; 91: 1367–1373
   PubMed Web of Science ®Google Scholar
• Leppäluoto J., Ruskoaho H. Endothelin peptides: Biological activities, cellular signalling and clinical significance. Annals of Medicine 1992; 24: 153–161
   PubMed Web of Science ®Google Scholar
• Lerman A., Edwards B. S., Hallett J. W., Heublein D. M., Sandberg S. M., Barnett J. J. C., Jr. Circulating and tissue endothelin immunoreacitivity in advanced atherosclerosis. New England Journal of Medicine 1991; 325: 997–1001
   PubMed Web of Science ®Google Scholar
• Lundborg M., Wong J., Hintze T. H. Mechanism of nitro-L-arginine induced hypertension in conscious dogs. FASEB Journal 1993; 7: A747
   Web of Science ®Google Scholar
• Miller M. J. S., Pinto A., Mullane K. M. Impaired endothelium-dependent relaxations in rabbits subjected to aortic coarctation hypertension. Hypertension 1987; 10: 164–170
   PubMed Web of Science ®Google Scholar
• Miller M. J. S., Sadowska-Krowicka H., Chotinaruemol S., Kakkis J. L., Clark D. A. Amelioration of chronicileitis by nitric oxide synthase inhibition. Journal of Pharmacology and Experimental Therapeutics 1993; 264: 11–16
   PubMed Web of Science ®Google Scholar
• Miller M. J. S., Munshi U. K., Sadowska-Krowicka H., Kakkis J. L., Zhang X.-J., Eloby-Childress S., Clark D. A. Inhibition of calcium-dependent nitric oxide synthase causes ileitis and leukocytosis in guinea pigs. Digestive Diseases and Sciences 1994; 39: 1185–1192
   PubMed Web of Science ®Google Scholar
• Miller M. J. S., Clark D. A. Nitric oxide synthase inhibition can initiate or prevent gut inflammation: role of enzyme source. Agents and Actions 1994; 41: C231–C232
   Google Scholar
• Moncada S., Palmer R. M. J., Higgs E. A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacology Reviews 1991; 43: 109–142
   PubMed Web of Science ®Google Scholar
• Nakaki T., Nakayama M., Kato R. Inhibition by nitric oxide and nitric oxide-producing vasodilators of DNA synthesis in vascular smooth muscle cells. European Journal of Pharmacology 1990; 1898: 347–351
   Google Scholar
• Panza J. A., Quyyumi A. A., Brush J. E., Jr., Epstein S. E. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. New England Journal of Medicine 1990; 323: 22–27
   PubMed Web of Science ®Google Scholar
• Rossaint R., Falke K. J., Lopez F., Slama K., Pison U., Zapol W. M. Inhaled nitric oxide for the adult respiratory distress syndrome. New England Journal of Medicine 1993; 328: 399–405
   PubMed Web of Science ®Google Scholar
• Rubanyi G. M., Parker Botelho L. H. Endothelins. FASEB Journal 1991; 5: 2713–2720
   PubMed Web of Science ®Google Scholar
• Salminen K., Tikkanen I., Saijonmaa O., Nieminen M., Fyhrquist F., Frick M. H. Modulation of coronary tone in acute myocardial infarction by endothelin. Lancet 1989; ii: 747
   Google Scholar
• Savage P., Jeng A. Y. Quantitation of plasma endothelin. Analytical Biochemistry 1993, in press
   Google Scholar
• Weyrich A. S., Ma X.-L., Lefer A. M. The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat. Circulation 1992; 86: 279–288
   PubMed Web of Science ®Google Scholar